| Date | Title | Description |
| 10.06.2026 | Zilliz Launches Vector Lakebase, Extending the World's Most Adopted Vector Database into a Unified Data Platform for AI | Available now in public preview on Zilliz Cloud, Vector Lakebase keeps production vector search at its core and adds shared lake-native storage and on-demand compute — bringing real-time serving, interactive discovery, and batch analytics o... |
| 21.04.2026 | Metis TechBio clears key listing hurdle with AI nanodelivery focus | On April 19, Metis TechBio (stylized as “METiS TechBio”) announced that it had cleared its listing hearing at Hong Kong Exchanges and Clearing (HKEX), a key step toward a Hong Kong IPO.
Jefferies, Deutsche Bank, and CITIC Securities are act... |
| 04.04.2026 | Syneron Bio Fuels Innovation with $150M Investment | Syneron Bio secured $150 million in Series B financing. This major investment drives its intelligent Synova platform. The capital fuels advanced macrocyclic peptide drug discovery. It targets critical unmet needs across oncology, autoimmune... |
| 03.04.2026 | Syneron Bio Closes $150M Series B Financing | Syneron Bio, a Beijing, China-based intelligent platform-driven macrocyclic peptide drug discovery company, closed a $150m Series B financing round.
The round was led by an international life-science fund, with co-lead participation from De... |
| 03.04.2026 | Syneron Bio Announces Completion of $150 Million Series B Financing | BEIJING, April 3, 2026 /PRNewswire/ -- Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on March 31th. The round was led by an international ... |
| 03.04.2026 | Syneron Bio: $150 Million Raised For Macrocyclic Peptide Drug Discovery Platform And Pipeline Advancement | Syneron Bio announced the completion of a $150 million Series B financing round, strengthening its position as a developer of intelligent platform-driven macrocyclic peptide therapeutics and accelerating its push toward clinical development... |
| 27.03.2026 | Zilliz Cloud Launches Native Cross-Region Disaster Recovery for Vector Databases | New Global Cluster and Global Endpoint capabilities deliver automated failover with near-zero downtime for enterprise AI applications
REDWOOD CITY, Calif., March 27, 2026 /PRNewswire/ -- Zilliz, the company behind Milvus, the world's most w... |
| 22.03.2026 | Excalipoint Therapeutics Secures $68.7M for Next-Gen TCE Therapies | Excalipoint Therapeutics, a dynamic Shanghai-based biotechnology firm, secured $68.7 million in oversubscribed seed funding. This substantial capital propels its mission to redefine T-cell engager (TCE) therapies. The company is tackling si... |
| 20.03.2026 | Zilliz Cloud Launches Customer-Managed Encryption Keys for Enterprise Data Sovereignty | New CMEK capability gives regulated enterprises full control over encryption keys for AI-scale vector workloads
REDWOOD CITY, Calif., March 20, 2026 /PRNewswire/ -- Zilliz, the company behind Milvus, the world's most widely adopted open-sou... |
| 18.03.2026 | Excalipoint Therapeutics: $68.7 Million Raised For Next-Generation T-Cell Engager Therapies | Excalipoint Therapeutics, a clinical-stage biotechnology company focused on next-generation T-cell engager therapies, announced the close of an oversubscribed $68.7 million seed financing round to advance its proprietary platforms and pipel... |
| 18.03.2026 | Excalipoint Therapeutics Raises $68.7M in Seed Funding | Excalipoint Therapeutics, a Shanghai, China-based biotechnology company developing T-cell engager (TCE) therapies for cancer and autoimmune diseases, raised $68.7M in Seed funding.
Backers included HSG, Apricot Capital, Yuanbio Venture Capi... |
| 16.03.2026 | Китайский AI-стартап Moonshot привлекает средства при оценке $18 млрд | Китайский стартап в сфере искусственного интеллекта Moonshot AI планирует привлечь до $1 млрд в рамках расширенного инвестиционного раунда, который может оценить компанию примерно в $18 млрд. Это более чем в четыре раза выше оценки компании... |
| 12.03.2026 | Zilliz Open-Sources Memsearch, Giving AI Agents Persistent, Human-Readable Memory | New open-source library lets developers give any AI agent long-term memory that humans can read, edit, and trust—extracted from OpenClaw's viral memory system and powered by the Milvus vector database.
REDWOOD CITY, Calif., March 12, 2026 /... |
| 11.03.2026 | Dify Secures $30M To Propel Open-Source AI Deployment | Dify, a Menlo Park-based innovator, just closed a $30 million Series Pre-A funding round. The valuation now stands at $180 million. The company provides a crucial open-source platform. It enables teams to construct, deploy, and manage produ... |
| 10.03.2026 | Dify: $30 Million Raised For Open-Source AI Application Platform In Series Pre-A Round | Dify, a Menlo Park, California-based provider of an open-source platform that helps teams build, deploy, and operate production-grade AI applications and agentic workflows, announced it has raised $30 million in series pre-A funding at a $1... |
| 09.03.2026 | Dify Raises $30M in Series Pre-A Funding | Dify, a Menlo Park, CA-based provider of an open-source platform that helps teams build, deploy, and operate production-grade AI applications and agentic workflows, raised $30M in Series Pre-A funding, at a $180M valuation.
The round was le... |
| 28.02.2026 | Zilliz Cloud Brings BYOC to Azure, Extending Availability Across Major Cloud Platforms | REDWOOD CITY, Calif., Feb. 28, 2026 /PRNewswire/ -- Zilliz, the company behind Milvus, the world's most widely adopted open-source vector database, today announced the general availability of Zilliz Cloud BYOC (Bring Your Own Cloud) on Micr... |
| 20.02.2026 | Moonshot AI sparks investor frenzy as Z.ai and MiniMax reset valuation benchmarks | As fireworks lit up the sky during the Lunar New Year, another kind of frenzy was unfolding in China’s large model industry.
At one end, tech giants were spending heavily on “red packet” giveaways and free beverage promotions to draw users ... |
| 13.02.2026 | Zilliz Cloud Expands European Presence with New AWS Region in Ireland | REDWOOD CITY, Calif., Feb. 13, 2026 /PRNewswire/ -- Zilliz, the company behind the most popular open-source vector database Milvus, recently announced the availability of a new Zilliz Cloud region in AWS eu-west-1 (Ireland), further expandi... |
| 31.01.2026 | Zilliz Open Sources Industry-First Bilingual "Semantic Highlighting" Model to Slash RAG Token Costs and Boost Accuracy | REDWOOD CITY, Calif., Jan. 31, 2026 /PRNewswire/ -- Zilliz, the company behind the leading open-source vector database Milvus, today announced the open-source release of its Bilingual Semantic Highlighting Model, an industry-first AI model ... |
| 29.01.2026 | As AI consolidates, what makes StepFun worth a RMB 5 billion raise? | StepFun’s Series B+ funding round, exceeding RMB 5 billion (USD 700 million), has drawn attention for its size. The investor mix and the speed at which the round closed are equally revealing. From launch to completion, the process took roug... |
| 20.01.2026 | Malaysia's Crewstone backs Chinese AIoT firm Uni-Ubi in $74m round | - |
| 14.01.2026 | China Deal Review: Market rebound drives startup funding to $5.5b in Dec | - |
| 21.12.2025 | Syneron Bio Raises Nearly $100M in Series A and A+ Funding Rounds | Syneron Bio, a Beijing, China-based developer of an intelligent high-throughput macrocyclic peptide drug discovery platform, raised nearly $100m in Series A and A+ funding rounds.
Backers included AstraZeneca, Pfizer Biotech Development Inv... |
| 19.12.2025 | Milvus Surpasses 40,000 GitHub Stars, Reinforcing Leadership in Open-Source Vector Databases | As Gartner Predicts Vector Databases Will Be Used in 30% of Enterprise Applications by 2026, Milvus Reaches Major Milestone with 10,000+ Production Deployments
REDWOOD CITY, Calif., Dec. 19, 2025 /PRNewswire/ -- Zilliz recently announced th... |
| 18.12.2025 | Allink Biotherapeutics Secures $47 Million, Propels Next-Gen Cancer and Immunology Therapies | Allink Biotherapeutics raised $47 million in Series A extension funding. This capital accelerates two critical antibody-drug conjugate (ADC) programs, ALK201 and ALK202, into global Phase I clinical trials. The biotech also expands its mult... |
| 16.12.2025 | Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development | The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with strong backing from both new investors and existing supporters
Proceeds to advance two differentiated and highly c... |
| 16.12.2025 | Allink Biotherapeutics: $47 Million Series A Extension Raised To Advance Two ADC Programs And Expand Multispecific Platforms | Allink Biotherapeutics, a Shanghai-based clinical-stage biotechnology company developing antibody drug conjugates and multi-specific antibody therapeutics for oncology and immunology, has completed extension rounds of its Series A financing... |
| 14.07.2025 | Zilliz Cloud Expands Global Footprint with New Azure Region in Central India | New region empowers customers to meet data sovereignty, regulatory, low-latency, and cost-efficiency goals when building AI applications.
REDWOOD SHORES, Calif., July 14, 2025 /PRNewswire/ -- Zilliz, the company behind the most popular open... |
| 18.06.2025 | Zilliz Launches Milvus Ambassador Program to Empower AI Infrastructure Advocates Worldwide | Global initiative recognizes passionate individuals building the future of AI-powered vector search through open-source vector database technology
SAN FRANCISCO, June 18, 2025 /PRNewswire/ -- Zilliz, the company behind the leading open-sour... |
| 20.07.2023 | The Week in AgriFoodTech: Keurig Dr Pepper bets $300m on coffee, Simbe Robotics scores $28m | Big news this week came from CPG Keurig Dr Pepper, which scooped up a 33% stake in a coffee company, while several food robotics companies that raised new funding. Elsewhere, US-based CubicAcres raised funding and launched a partnership wit... |
| 09.08.2021 | The largest Chinese investors you’ve never heard of | |
| 28.10.2020 | Morningside Venture Capital Rebrands as 5Y Capital | Morningside Venture Capital, a Shangai, China-based investment firm, has changed its name to 5Y Capital.
The new name “5Y” is a combination of the number 5 in the Chinese name of “Wuyuan Road” (wu means 5 in Chinese) and the first letter of... |
